Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 8/20 | 0.54 |
| ▸ | AGTR2 | P50052 | 8/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6170161 | 0.90 | AGTR1 (0.66) | AGTR1AGTR2KDM4EALDH1A1LMNA | |
| SCHEMBL7670036 | 0.89 | AGTR1 (0.57) | AGTR1AGTR2KDM4EALDH1A1LMNA | |
| SCHEMBL7675595 | 0.87 | AGTR1 (0.53) | AGTR1AGTR2KDM4EALDH1A1LMNA | |
| SCHEMBL7676720 | 0.87 | TDP1 (0.55) | AGTR1AGTR2KDM4EALDH1A1LMNA | |
| SCHEMBL169971 | 0.86 | KDM4E (0.53) | AGTR1AGTR2KDM4EALDH1A1LMNA | |
| SCHEMBL6169187 | 0.83 | AGTR1 (0.52) | AGTR1AGTR2KDM4EALDH1A1LMNA | |
| SCHEMBL6170375 | 0.83 | AGTR1 (0.62) | AGTR1AGTR2TDP1TP53 | |
| SCHEMBL7671121 | 0.83 | AGTR1 (0.54) | AGTR1AGTR2KDM4EALDH1A1HPGD | |
| SCHEMBL7671757 | 0.83 | TP53 (0.59) | AGTR1AGTR2TDP1TP53 | |
| SCHEMBL7676367 | 0.83 | AGTR1 (0.49) | AGTR1AGTR2KDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6352985-B1 | CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-03-05 | — | — | US | disclosed |
| EP-1132087-A1 | REMEDIES FOR POLYCYSTIC OVARY SYNDROME | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-09-12 | — | — | EP | disclosed |
| US-6166219-A | Benzimidazole derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-12-26 | — | — | US | disclosed |
| EP-0882718-A1 | BENZIMIDAZOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-12-09 | — | — | EP | disclosed |